A trial that failed because of poor recruitment [2]

Palliative Medicine

Volumn 17, Issue 6, 2003, Pages 557-

  Edmonds, Polly ^a   Lucas, Caroline ^b  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b PRINCESS ALICE HOSPICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SCOPOLAMINE BUTYL BROMIDE;

CANCER PALLIATIVE THERAPY; CLINICAL RESEARCH; FINANCIAL MANAGEMENT; HOSPITAL ADMISSION; HUMAN; INTERPERSONAL COMMUNICATION; INTESTINE CANCER; INTESTINE OBSTRUCTION; INTRAVENOUS FEEDING; LETTER; METHODOLOGY; NASOGASTRIC TUBE; PATIENT CARE; PATIENT SELECTION; PHYSICIAN ATTITUDE; RETROSPECTIVE STUDY; SAMPLE SIZE; SAMPLING; SURGEON; TERMINAL CARE; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM;

BUTYLSCOPOLAMMONIUM BROMIDE; CLINICAL TRIALS, PHASE II; HUMANS; INTESTINAL OBSTRUCTION; MULTICENTER STUDIES; NEOPLASMS; PATIENT SELECTION;

EID: 0141813592     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/026921630301700614     Document Type: Letter

References (1)

1. Hardy J, Ling J, Mansi J, Isaacs R, Bliss J, A'Hem R, Blake P, Gore M, Shepherd J, Hanks G. Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliat Med 1998; 12: 437-42.